guselkumab,Risankizumab
janssen,abbvie
[' gus ']
#spa posters #acr22 1487. differentiation of therapeutic ab targeting il-23 compared with ris, gus uniquely binds both cd64+ myeloid cells &amp; il-23
cd64+ mononuclear phagocytes are enriched in pso skin &amp; serve as dominant il-23 source dennis mcgonagle #acrambassador
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books